Computer-based image studies on tumor nests mathematical features of breast cancer and their clinical prognostic value

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Wang, Lin Wei ^a   Qu, Ai Ping ^b   Yuan, Jing Ping ^a   Chen, Chuang ^c   Sun, Sheng Rong ^c   Hu, Ming Bai ^a   Liu, Juan ^b   Li, Yan ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER GRADING; CANCER MORPHOLOGY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COMPUTER AIDED DESIGN; COMPUTER ANALYSIS; DISEASE FREE SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGING SOFTWARE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; MIDDLE AGED; NEOPLASM; PROCESS DEVELOPMENT; SURVIVAL TIME; TISSUE MICROARRAY; TUMOR NEST;

AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; ROC CURVE;

EID: 84892582389     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082314     Document Type: Article

References (41)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Fan L, Zheng Y, Yu KD, Liu GY, Wu J, et al. (2009) Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat 117: 409-416.
3. Hou N, Huo D (2013) A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase. Breast Cancer Res Treat 138(2): 633-641.
4. Johnson RH, Chien FL, Bleyer A (2013) Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009. JAMA 309: 800-805.
5. McLaughlin SA (2013) Surgical management of the breast: breast conservation therapy and mastectomy. Surg Clin North Am 93: 411-428.
6. Zhang B, Song Q, Tang Z, Xie X, Yang H, et al. (2013) A 10-year (1999 approximately 2008) retrospective multi-center study of breast cancer surgical management in various geographic areas of China. Breast 22(5): 676-681.
7. Cuzick J, Dowsett M, Pineda S, Wale C, Salter J, et al. (2011) Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer. J Clin Oncol 29: 4273-4278.
8. Park YH, Lee SJ, Cho EY, Choi YL, Lee JE, et al. (2011) Clinical relevance of TNM staging system according to breast cancer subtypes. Ann Oncol 22: 1554-1560.
9. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ (2012) World Health Organization classification of tumours of the breast, fourth edition. IARC, Lyon, France.
10. Elston CW, Gresham GA, Rao GS, Zebro T, Haybittle JL, et al. (1982) The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects. Br J Cancer 45: 655-669.
11. Beck AH, Sangoi AR, Leung S, Marinelli RJ, Nielsen TO, et al. (2011) Systematic analysis of breast cancer morphology uncovers stromal features associated with survival. Sci Transl Med 3: 108ra113.
12. Yuan Y, Failmezger H, Rueda OM, Ali HR, Graf S, et al. (2012) Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling. Sci Transl Med 4: 157ra143.
13. Tawfik O, Kimler BF, Davis M, Stasik C, Lai SM, et al. (2007) Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count. Virchows Arch 450: 627-636.
14. Allred DC, Wu Y, Mao S, Nagtegaal ID, Lee S, et al. (2008) Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin Cancer Res 14: 370-378.
15. Roylance R, Gorman P, Harris W, Liebmann R, Barnes D, et al. (1999) Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res 59: 1433-1436.
16. Rizki A, Bissell MJ (2004) Homeostasis in the breast: it takes a village. Cancer Cell 6: 1-2.
17. Peng CW, Liu XL, Chen C, Liu X, Yang XQ, et al. (2011) Patterns of cancer invasion revealed by QDs-based quantitative multiplexed imaging of tumor microenvironment. Biomaterials 32: 2907-2917.
18. Liu XL, Peng CW, Chen C, Yang XQ, Hu MB, et al. (2011) Quantum dots-based double-color imaging of HER2 positive breast cancer invasion. Biochem Biophys Res Commun 409: 577-582.
19. Tambasco M, Eliasziw M, Magliocco AM (2010) Morphologic complexity of epithelial architecture for predicting invasive breast cancer survival. J Transl Med 8: 140.
20. Di Cataldo S, Ficarra E, Macii E (2012) Computer-aided techniques for chromogenic immunohistochemistry: status and directions. Comput Biol Med 42: 1012-1025.
21. Gurcan MN, Boucheron LE, Can A, Madabhushi A, Rajpoot NM, et al. (2009) Histopathological image analysis: a review. IEEE Rev Biomed Eng 2: 147-171.
22. Altunbay D, Cigir C, Sokmensuer C, Gunduz-Demir C (2010) Color graphs for automated cancer diagnosis and grading. IEEE Trans Biomed Eng 57: 665-674.
23. Chen C, Sun SR, Gong YP, Qi CB, Peng CW, et al. (2011) Quantum dots-based molecular classification of breast cancer by quantitative spectroanalysis of hormone receptors and HER2. Biomaterials 32: 7592-7599.
24. Chen C, Peng J, Xia H, Wu Q, Zeng L, et al. (2010) Quantum-dot-based immunofluorescent imaging of HER2 and ER provides new insights into breast cancer heterogeneity. Nanotechnology 21: 095101.
25. Chen C, Peng J, Xia HS, Yang GF, Wu QS, et al. (2009) Quantum dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancer. Biomaterials 30: 2912-2918.
26. Chen C, Xia HS, Gong YP, Peng J, Peng CW, et al. (2010) The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis. Biomaterials 31: 8818-8825.
27. Wittekind C, Mwyer HJ (2009) TNM classification of malignant tumours (ed 7). Wiley, Weinheim, Germany.
28. Peng CW, Liu XL, Liu X, Li Y (2010) Co-evolution of cancer microenvironment reveals distinctive patterns of gastric cancer invasion: laboratory evidence and clinical significance. J Transl Med 8: 101.
29. Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10: 7252-7259.
30. Greaves P, Clear A, Coutinho R, Wilson A, Matthews J, et al. (2013) Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome. J Clin Oncol 31: 256-262.
31. Velcheti V, Schalper K, Yao X, Cheng H, Kocoglu M, et al. (2013) High SOX2 levels predict better outcome in non-small cell lung carcinomas. PLoS One 8: e61427.
32. Ginsburg GS, Willard HF (2009) Genomic and personalized medicine: foundations and applications. Transl Res 154: 277-287.
33. Peng CW, Tian Q, Yang GF, Fang M, Zhang ZL, et al. (2012) Quantum-dots based simultaneous detection of multiple biomarkers of tumor stromal features to predict clinical outcomes in gastric cancer. Biomaterials 33: 5742-5752.
34. Cheng WY, Ou Yang TH, Anastassiou D (2013) Development of a prognostic model for breast cancer survival in an open challenge environment. Sci Transl Med 5: 181ra150.
35. Damasco C, Lembo A, Somma MP, Gatti M, Di Cunto F, et al. (2011) A signature inferred from Drosophila mitotic genes predicts survival of breast cancer patients. PLoS One 6: e14737.
36. Basavanhally A, Ganesan S, Feldman M, Shih N, Mies C, et al. (2013) Multi-Field-of-View Framework for Distinguishing Tumor Grade in ER+ Breast Cancer from Entire Histopathology Slides. IEEE Trans Biomed Eng 60(8):2089-2099.
37. Ozdemir E, Sokmensuer C, Gunduz-Demir C (2012) A resampling-based Markovian model for automated colon cancer diagnosis. IEEE Trans Biomed Eng 59: 281-289.
38. Dundar MM, Badve S, Bilgin G, Raykar V, Jain R, et al. (2011) Computerized classification of intraductal breast lesions using histopathological images. IEEE Trans Biomed Eng 58: 1977-1984.
39. Sertel O, Kong J, Catalyurek UV, Lozanski G, Saltz JH, et al. (2009) Histopathological Image Analysis Using Model-Based Intermediate Representations and Color Texture: Follicular Lymphoma Grading. J Signal Process Syst 55: 169-183.
40. Kong J, Sertel O, Shimada H, Boyer KL, Saltz JH, et al. (2009) Computer-aided evaluation of neuroblastoma on whole-slide histology images: Classifying grade of neuroblastic differentiation. Pattern Recognition 42: 1080-1092.
41. Tabesh A, Teverovskiy M, Pang HY, Kumar VP, Verbel D, et al. (2007) Multifeature prostate cancer diagnosis and Gleason grading of histological images. IEEE Trans Med Imaging 26: 1366-1378.